Document detail
ID

doi:10.1186/s12866-023-03080-9...

Author
Basardeh, Eilnaz Piri-Gavgani, Somayeh Moradi, Hamid Reza Azizi, Masoumeh Mirzabeigi, Parastoo Nazari, Farzaneh Ghanei, Mostafa Mahboudi, Fereidoun Rahimi-Jamnani, Fatemeh
Langue
en
Editor

BioMed Central

Category

Mycology

Year

2024

listing date

2/14/2024

Keywords
... pneumonia immunotherapy scfv bactericidal antibodies results scfvs
Metrics

Abstract

Background The emergence of carbapenem-resistant and extensively drug-resistant (XDR) Acinetobacter baumannii as well as inadequate effective antibiotics calls for an urgent effort to find new antibacterial agents.

The therapeutic efficacy of two human scFvs, EB211 and EB279, showing growth inhibitory activity against A. baumannii in vitro , was investigated in immunocompromised mice with A. baumannii pneumonia.

Results The data revealed that infected mice treated with EB211, EB279, and a combination of the two scFvs showed better survival, reduced bacterial load in the lungs, and no marked pathological abnormalities in the kidneys, liver, and lungs when compared to the control groups receiving normal saline or an irrelevant scFv.

Conclusions The results from this study suggest that the scFvs with direct growth inhibitory activity could offer promising results in the treatment of pneumonia caused by XDR A. baumannii.

Basardeh, Eilnaz,Piri-Gavgani, Somayeh,Moradi, Hamid Reza,Azizi, Masoumeh,Mirzabeigi, Parastoo,Nazari, Farzaneh,Ghanei, Mostafa,Mahboudi, Fereidoun,Rahimi-Jamnani, Fatemeh, 2024, Anti-Acinetobacter Baumannii single-chain variable fragments provide therapeutic efficacy in an immunocompromised mouse pneumonia model, BioMed Central

Document

Open

Share

Source

Articles recommended by ES/IODE AI

High-Frequency Repetitive Magnetic Stimulation at the Sacrum Alleviates Chronic Constipation in Parkinson’s Patients
magnetic stimulation parkinson’s significant patients scale sacrum pd hf-rms chronic constipation scores
The mechanism of PFK-1 in the occurrence and development of bladder cancer by regulating ZEB1 lactylation
bladder cancer pfk-1 zeb1 lactylation glycolysis inhibits lactate glucose bc pfk-1 cancer lactylation cells bladder